Euclidean Capital »

Surrozen shares owned by Euclidean Capital

Quarter-by-quarter ownership of Surrozen (SRZNW) shares owned by Euclidean Capital from 13F filings

Historical chart of Euclidean Capital investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by Euclidean Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by Euclidean Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.3k 171k 0.02
2023-09-30 $7.0k 171k 0.04

More positions owned by Euclidean Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Msci India Etf (INDA)
Rapt Therapeutics (RAPT)
Alector (ALEC)
Foghorn Therapeutics (FHTX)
23andme Holding Class A Com (ME)
Oric Pharmaceuticals (ORIC)
Pmv Pharmaceuticals (PMVP)
Tenaya Therapeutics (TNYA)
Ngm Biopharmaceuticals (NGM)
Surrozen Com New (SRZN)
Surrozen *w Exp 08/01/203 (SRZNW)

View all positions for Euclidean Capital

Top funds holding Surrozen

Baker Bros. Advisors
LMR Partners
Bridger Management
Altitude Crest Partners
Euclidean Capital
Deerfield Management Company
Perceptive Advisors
Arrowpoint Asset Management
Samsara BioCapital
Millennium Management
Boxer Capital
EcoR1 Capital
Cantor Fitzgerald, L. P.
Highbridge Capital Management
Cowen And Company

View all funds holding Surrozen